Use of glutamate, glutamate derivatives or metabolites, glutamate analogues or mixtures thereof for the manufacture of a composition for the treatment of osteoporosis

Details for Australian Patent Application No. 2002366111 (hide)

International Classifications

Event Publications

14 August 2003 Complete Application Filed

Priority application(s): 0201713-5 06.06.02 SE; 0104385-0 21.12.01 SE; 0103932-0 23.11.01 SE

21 August 2003 Application Open to Public Inspection

Published as AU-B-2002366111

28 June 2007 Application Accepted

Published as AU-B-2002366111

5 July 2007 Corrigenda

Applications Accepted - Name Index Under the name Essentys AB, Application No. 2002366111, under INID (54), correct the invention title to read Use of glutamate, glutamate derivates or metabolites, glutamate analogues or mixtures thereof for the manufacture of a composition for the treatment of osteoporosis Specifications Republished The following specifications contained errors when advertised OPI, Accepted or Certified. They have been reissued on the AU-A or AU-B CD-ROM of this Journal date. 2001250818 Vi

25 October 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.